In contrast to C. trachomatis, C. pneumoniae and C. psittaci are able to infect different type of cells such as alveolar macrophages, human monocytes and endothelial cells. This explains the easy access to different organs of the host and the presence of chlamydia and their structural components into the circulation. These components can bind to antibodies present in the blood and form immune complexes which maintain inflammatory reactions in the vascular system. Infections in untreated man and animals with C. psittaci sometimes are very severe and may lead to death underlying the importance of the acute phase of these infections. One can notice that the exact physiopathology of this death is not fully understood. Is the endotoxin of C. psittaci far more aggressive than the one found in C. trachomatis? For those who recovered the questions of host resistance and immunity arise. As underlined by Storz 33 to understand this problem of natural resistance and acquired immunity one has to consider the nature of these infectious agents as obligate intracellular parasites and their possibility to remain latent. Article 
IMMUNITY FOLLOWING NATURAL INFECTIONS
Immunity following chlamydiosis is difficult to study but seems to T-cell mediated immunity against C. pneumoniae has thus far been studied in persons who have acquired a laboratory infection caused by C. pneumoniae strain Kajaani 6. 34 A definite antigen-specific lymphocyte proliferation response, which started to increase at 3 weeks and had a peak value at [8] [9] weeks after the onset of symptoms, was recorded.
T-cell responses to C. pneumoniae antigens are significantly stronger in healthy, seropositive individuals than in seronegative persons. In contrast to healthy individuals in whom the T-cell reactivity is specific to C. pneumoniae antigens, we have recently observed that patients with severe coronary heart disease elicit a T-cell response that is cross-reactive with different chlamydial species and which might be directed against conserved protein epitopes in MOMP or even against chlamydial heat shock proteins shared by different chlamydial species. Moreover, high antibody titers to C. pneumoniae in patients with coronary heart disease were often associated with a decreased T-cell reactivity against C. pneumoniae. These preliminary results suggest that T-cell immunity might be important in the protection against C. pneumoniae, and that in chronic infections or in reinfections T-cells may also be responsible for the immunopathological processes associated with the disease.
It has been shown that C. pneumoniae is capable of inducing ILl and TNF production in human monocytes. 13 We have also shown that in acute C. pneumoniae pneumonia, triglyceride levels are significantly higher and HDL levels, particularly HDL2, significantly lower than in either viral or pneumococcal pneumonias. It can be speculated that in chronic C. pneumoniae infections the continuous production of TNF might lead to a serum lipid pattern similar to that which is considered as a risk factor for coronary heart disease.
Recent data 17 The results from animal studies suggest that antibodies, i.e. humoral immunity, may contribute to protection and that the strong inflammatory response seen in the lungs after the rechallenge of mice with C. pneumoniae may be due to the immunodestructive action of T-cell mediated immunity.
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